Dynamic Technology Lab’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,352
| Closed | -$86K | – | 925 |
|
|
2024
Q3 | $86K | Sell |
11,352
-28,807
| -72% | -$218K | 0.01% | 945 |
|
|
2024
Q2 | $248K | Buy |
+40,159
| New | +$248K | 0.03% | 735 |
|
|
2023
Q4 | – | Sell |
-22,609
| Closed | -$160K | – | 1044 |
|
|
2023
Q3 | $160K | Sell |
22,609
-16,216
| -42% | -$115K | 0.02% | 819 |
|
|
2023
Q2 | $273K | Buy |
+38,825
| New | +$273K | 0.03% | 739 |
|
|
2022
Q3 | – | Sell |
-27,257
| Closed | -$288K | – | 1132 |
|
|
2022
Q2 | $288K | Buy |
27,257
+9,240
| +51% | +$97.6K | 0.03% | 777 |
|
|
2022
Q1 | $293K | Buy |
+18,017
| New | +$293K | 0.03% | 797 |
|
|
2021
Q4 | – | Sell |
-26,774
| Closed | -$385K | – | 1126 |
|
|
2021
Q3 | $385K | Buy |
+26,774
| New | +$385K | 0.05% | 640 |
|
|
2020
Q3 | – | Sell |
-20,284
| Closed | -$97K | – | 999 |
|
|
2020
Q2 | $97K | Sell |
20,284
-29,051
| -59% | -$139K | 0.01% | 889 |
|
|
2020
Q1 | $99K | Buy |
+49,335
| New | +$99K | 0.02% | 891 |
|
|
2018
Q4 | – | Sell |
-16,036
| Closed | -$122K | – | 982 |
|
|
2018
Q3 | $122K | Buy |
+16,036
| New | +$122K | 0.02% | 938 |
|
|
2017
Q3 | – | Sell |
-25,885
| Closed | -$144K | – | 1037 |
|
|
2017
Q2 | $144K | Sell |
25,885
-14,305
| -36% | -$79.6K | 0.03% | 918 |
|
|
2017
Q1 | $337K | Buy |
+40,190
| New | +$337K | 0.08% | 504 |
|
|
2016
Q2 | – | Sell |
-19,107
| Closed | -$54K | – | 875 |
|
|
2016
Q1 | $54K | Buy |
+19,107
| New | +$54K | 0.01% | 868 |
|
|
2015
Q3 | – | Sell |
-14,397
| Closed | -$215K | – | 808 |
|
|
2015
Q2 | $215K | Buy |
+14,397
| New | +$215K | 0.07% | 595 |
|
|
2014
Q1 | – | Sell |
-15,790
| Closed | -$120K | – | 577 |
|
|
2013
Q4 | $120K | Buy |
15,790
+5,070
| +47% | +$38.5K | 0.08% | 455 |
|
|
2013
Q3 | $78K | Buy |
+10,720
| New | +$78K | 0.06% | 431 |
|